Research Quotations
Research Quotes from:
-
Analog Quotes
We like Analog Devices Ê( ADI : Research , Estimates ) because it's a leading company in the analog segment of the semiconductor industry -- and the analog segment I think this cycle is looking better than it's ever been because of the proliferation of the devices other than PCs. So Analog is riding on that curve. They're the fastest-growing analog company in the last several quarters, and it also has better margin than it ever had in its history, as a public company.
-
Analog Quotes
We like Analog Devices  ( ADI : Research , Estimates ) because it's a leading company in the analog segment of the semiconductor industry -- and the analog segment I think this cycle is looking better than it's ever been because of the proliferation of the devices other than PCs. So Analog is riding on that curve. They're the fastest-growing analog company in the last several quarters, and it also has better margin than it ever had in its history, as a public company.
-
Best Quotes
We know from social research that traditional family structure is the best place that children can possibly be raised, So, yeah, I want my child to grow up in a Virginia that continues to put mom and dad as the model and holds them up and says, ultimately, what we want to see happen -- this is what we as a government want to protect and promote.
-
Affecting Quotes
We are proud to bring the world-renowned leader in diabetes care and education to the Las Vegas Valley. Diabetes is a major disease affecting our local community at a rate that exceeds both state and national norms. If not properly treated, it can be a life threatening and debilitating. We look forward to working with the Joslin staff in Boston to ensure that our care meets the standards of this international leader in diabetes treatment, research and education.
-
Across Quotes
We are proud of what the Partnership for Prescription Assistance has accomplished in this short period of time. But our job isn't done. Research shows there are thousands more people in Virginia and across the country who could benefit if they simply knew patient assistance programs were available. We are committed to reaching every one of them.
-
Advanced Quotes
We are pleased with our performance in 2005. The year was highlighted by the filing of the new drug application on NRP104, our lead compound under development, for the treatment of Attention Deficit Hyperactivity Disorder in pediatric populations. We believe that this advancement together with the progress on our other pipeline products positions us well for future growth. Looking forward, we anticipate receiving approval from the FDA on NRP104 in the second half of 2006 and making IND filings on NRP409 and NRP388, the two most advanced candidates in our preclinical pipeline, by the end of the second quarter of 2006. In addition, we plan to continue to develop NRP290, our second most advanced compound, and other drug products in our research pipeline.